WuXi PharmaTech Strengthens Senior Scientific Team with Three Excellent Additions
Apr 12, 2004
April 12, 2004 - Shanghai, China - WuXi PharmaTech, a leading chemistry-based R&D service company based in China, recently announced the appointments of:
-- Dr. Shu-Hui Chen as Chief Scientific Officer -- Dr. Suhan Tang as Vice President of Process R&D -- Dr. Ning Zhao as Vice President of Analytical R&D and QA
"We are very excited to have added these three talented individuals to our senior scientific management team. We are certain their extensive experience and innovativeness will help facilitate the accelerating growth of WuXi PharmaTech," said Dr. Ge Li, Chief Executive Officer and founder of WuXi PharmaTech.
Dr. Chen joins WuXi PharmaTech after a distinguished tenure as Senior Research Scientist at Eli Lilly and Company. Prior to that Dr. Chen worked in research at Vion Pharmaceuticals and Bristol-Myers Squibb. Dr. Chen has more than 13 years' industry experience, 80 publications and more than 30 issued patents and applications to his credit. He holds a Ph.D. in organic chemistry from Yale University and a B.Sc. in chemistry from Fudan University, China.
Dr. Tang has spent the past eight years as Principal Scientist at Schering Plough Research Institute. Prior to that he spent eight years doing graduate and post doctoral research at Florida State University and Columbia University. He has nearly 20 publications to his credit. He holds a Ph.D. from Columbia University and a B.Sc. in chemistry from JiLin University, China.
Dr. Zhao comes to WuXi PharmaTech with over ten years' experience in analytical sciences and the pharmaceutical industry. Most recently she was Site Leader of Separation and Physical Sciences group, Discovery Analytical Sciences, at Bristol-Myers Squibb. Previously she worked for Pharmacopeia as a Group Leader and Wyeth Pharmaceuticals as a Senior Research Scientist. She has a total of 36 publications, patents, and presentations to her credit. She holds a Ph.D. from Columbia University and a B.Sc. in chemistry from Peking University, China.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.